Protein Restriction and Longevity: Can Limiting Protein Intake Support Healthy Aging?

University of Wisconsin researchers examine how reducing dietary protein intake may reshape nutrient sensing, metabolism, mitochondrial function, and other pathways linked to healthier aging.

(One of the leading authors on the Cell Press Blue article, Dr. Dudley Lamming | University of Wisconsin)

Researchers examine how restricting protein intake can improve metabolic health and influence aging-related pathways to extend healthspan and lifespan.

Aging &amp; Longevity

The Future of Longevity: Could Humans Really Live to 150?

A TIME Magazine longevity panel, featuring Harvard’s David Sinclair, explores whether breakthroughs in AI, cellular rejuvenation, and research on sex differences could help today’s children live far longer.

(An image illustrating the possibility of some humans achieving a 150-year lifespan in the future | NAD.com)

David Sinclair and Jennifer Garrison discuss whether AI advancements, cellular rejuvenation techniques, and research on sex differences can make a 150-year lifespan possible.

Bryan Johnson’s “Clone”: Where the Sci-Fi Ends and the Science Begins

The biohacker says his “newborn” clone could supply young blood, test experimental treatments, and eventually grow replacement organs.

(Bryan Johnson says he’s cloned himself, which could supply young blood, help test experimental treatments, and eventually grow replacement organs. | Futurism)

In the largest study of its kind, Viennese scientists analyzed over 25, 000 human tissue slices with AI to determine the architectural changes that occur with aging and how to predict disease. 


<p>Model: Six adults who received intravenous NAD+ and eight adults who received intravenous NR</p>
<p>Dosage: 500 mg of intravenous NAD+ or 500 mg of intravenous NR daily for four consecutive days</p>


Pilot Human Study Supports Safety of NAD+ IV and NR IV Infusions

A Stanford study supports the short-term safety of NAD+ and NR infusion therapies, and participants who received NR infusions exhibited significantly lower HbA1c (a blood test that reflects average blood sugar over two to three months).

(An IV bag containing a solution with NAD+ | Crete Fertility Centre)

A Stanford human trial provides the first data supporting the safety of NAD+ IV and NR IV therapies.

Search Result: kidney

Protein Restriction and Longevity: Can Limiting Protein Intake Support Healthy Aging?

The Future of Longevity: Could Humans Really Live to 150?

Bryan Johnson’s “Clone”: Where the Sci-Fi Ends and the Science Begins

Researchers Pull the Strings of Artificial Intelligence to Measure Aging: New Study

Pilot Human Study Supports Safety of NAD+ IV and NR IV Infusions